‘Gutted’: UK users of weight loss jab Mounjaro devastated by planned price hike | Pharmaceuticals industry

PEople using weight loss Jab Mounjaro reacted to the news that its manufacturer, Eli Lilly, plans to increase prices in the United Kingdom from September. Many people fear that they are unable to continue using the drug, which raises concerns for their mental and physical health.

For the trainee driving instructor Michael, the news is devastating. “I found something that changed my life and now let’s go,” said Brighton’s 52 -year -old player. “The only word that comes to mind is” emptied “.”

Michael’s starting weight in April was 91.5 kg and in just under five months, he lost 16 kg and is almost at his weight. Although it is “quite active”, making more than 17,000 steps a day, he does not believe that the weight will remain extinguished if he stops taking Mounjaro.

“I fought with weight all my life. I lost it in the past but it comes back. But by paying £ 330 for Mounjaro [after the price rise] is ridiculous. So losing what has been like a magic potion for me is a terrible shame.

His plan was to slowly reduce his use of the weight loss medication, but he fears that shortages prevent him. “I ordered two doses with a higher force and I will buy additional needles and try to” guess “my dose while counting the clicks. It pushed me to do what I don’t really want to do, but I don’t think I have a lot of choice. ”

Like many others, Polly, a retirement worker of the NHS in sixty Cardiff, said that the use of Mounjaro had “enormously changed” her life. Not only has she lost almost 25 kg, but with chronic obstructive pulmonary disease, she noticed that weight loss has reduced her respiratory problems. “It was difficult to climb stairs, but the difference is now incredible.”

But the rise in Mounjaro’s prices, it seems, is prohibitive. “I stretch financially but I can’t anymore,” she says.

Paid in private for weight loss blows and with approximately 15 kg to lose to be comfortably in its normal weight range, Polly will probably go to the use of Wegovy – a cheaper weight loss stroke produced by the Danish firm Novo Nordisk. “I dare not stop,” she says. “I can almost allow myself Mounjaro now because I spend less for food and not snacking, but I cannot justify the new cost.”

However, not everyone is eager to change, many readers reporting that they are comfortable with Mounjaro and fear that they will feel new side effects if they change. In addition, studies have suggested that Wegovy be less effective for weight loss.

For Christopher, 64, the Mounjaro price increases are a failure of the company from which he is ready to move away. “”[Eli Lilly] Have the choice of how they react to Trump and they seem to have chosen to make losses they could make in the United States to the British consumer. It’s disappointing, ”he says.

While he only started using Mounjaro in January after having decided to pay him in private, he has already lost about 20 kg. “I pay £ 205 a month for the maximum dose of 15 mg,” said Ware’s retirement lawyer, Hertfordshire. “It’s very expensive but effective.”

Christopher, who was trying to continue taking Mounjaro for a few more years, thinks that the price change will make him too much “luxury” for him.

“I think the way they went there is really bad. You are supposed to gradually accumulate your dose, therefore introduce price increases at a little short notice means that people who stop halfway up are likely to gain weight quickly.

“I could go to a cheaper alternative, but I expect that I will face disappointment once I stop taking Mounjaro.”